Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetirizine vs Diphenhydramine Pre-medication in MS Patients Receiving Anti-CD20 Therapy
NCT07472413Phase 3Not yet recruiting
- Sponsor
- University of Miami
- Start
- Nov 2026
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cetirizine in infusion reaction, sponsored by University of Miami. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
cetirizine
03
Conditions
infusion reaction
Beyond the preview
Go deeper on NCT07472413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07472413.